Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma

NCT05867004 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT05867004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05867004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma
Lead sponsor
Institut Claudius Regaud
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2023
Completion date
December 31, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune defect, melanoma, tumor skin